Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Its Synergism with L/S Polymorphism in the Promoter Region of Serotonin Transporter in Bipolar I Disorder Patients in Western Iran

Authors Information
Article Notes and Dates
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Farahmand Z, Tehrani-Doost M, Amini H, Mohammadi A, Mirzaei M, Mohamadzadeh A. Working Memory and Response Inhibition in Patients With Bipolar I Disorder During Euthymic Period. Iran J Psychiatry Behav Sci. 2015; 9(1)[DOI][PubMed]
  • 2. Mohammadi S, Khazaie H, Rahimi Z, Vaisi-Raygani A, Zargooshi N, Rahimi Z. The serotonin transporter (5-HTTLPR) but not serotonin receptor (5-HT2C Cys23Ser) variant is associated with bipolar I disorder in Kurdish population from Western Iran. Neurosci Lett. 2015; 590: 91-5[DOI][PubMed]
  • 3. Grzywacz A, Samochowiec A, Ciechanowicz A, Samochowiec J. Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol Rep. 2010; 62(5): 938-41[PubMed]
  • 4. Soeiro-de-Souza MG, Post RM, de Sousa ML, Missio G, do Prado CM, Gattaz WF, et al. Does BDNF genotype influence creative output in bipolar I manic patients? J Affect Disord. 2012; 139(2): 181-6[DOI][PubMed]
  • 5. Gruber O, Hasan A, Scherk H, Wobrock T, Schneider-Axmann T, Ekawardhani S, et al. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. Eur Arch Psychiatry Clin Neurosci. 2012; 262(1): 23-31[DOI][PubMed]
  • 6. Hashim H, Fawzy N, Fawzi MM, Karam RA. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients. J Psychiatr Res. 2012; 46(6): 762-6
  • 7. Neves FS, Malloy-Diniz L, Romano-Silva MA, Campos SB, Miranda DM, De Marco L, et al. The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord. 2011; 131(1-3): 307-11[DOI][PubMed]
  • 8. Carrard A, Salzmann A, Perroud N, Gafner J, Malafosse A, Karege F. Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism. Brain Behav. 2011; 1(2): 119-24[DOI][PubMed]
  • 9. Huang CC, Chang YH, Lee SY, Chen SL, Chen SH, Chu CH, et al. The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(5): 501-7[DOI][PubMed]
  • 10. Lee SY, Chen SL, Chen SH, Chu CH, Chang YH, Lin SH, et al. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 39(2): 382-7[DOI][PubMed]
  • 11. Chang YH, Lee SY, Chen SL, Tzeng NS, Wang TY, Lee IH, et al. Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord. 2013; 151(3): 967-72[DOI][PubMed]
  • 12. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet. 2005; 139B(1): 51-3[DOI][PubMed]
  • 13. Wang Z, Li Z, Gao K, Fang Y. Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis. BMC Psychiatry. 2014; 14: 366[DOI][PubMed]
  • 14. Correa H, Duval F, Mokrani MC, Bailey P, Tremeau F, Staner L, et al. Serotonergic function and suicidal behavior in schizophrenia. Schizophrenia Res. 2002; 56(1): 75-85
  • 15. Neves FS, Malloy-Diniz LF, Romano-Silva MA, Aguiar GC, de Matos LO, Correa H. Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients? J Affect Disord. 2010; 125(1-3): 98-102[DOI][PubMed]
  • 16. Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A. ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem. 2011; 346(1-2): 23-30[DOI][PubMed]
  • 17. Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, et al. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36(2): 264-70[DOI][PubMed]
  • 18. Ignacio ZM, Reus GZ, Abelaira HM, Quevedo J. Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression. Neuroscience. 2014; 275: 455-68[DOI][PubMed]
  • 19. Kudinova AY, Gibb BE, McGeary JE, Knopik VS. Brain derived neurotrophic factor (BDNF) polymorphism moderates the interactive effect of 5-HTTLPR polymorphism and childhood abuse on diagnoses of major depression in women. Psychiatry Res. 2015; 225(3): 746-7[DOI][PubMed]

Iranian Journal of Psychiatry and Behavioral Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check